The purpose of this study is to investigate the prognostic impact of spread through air spaces (STAS) in invasive mucinous adenocarcinoma (IMA). From 2015 to 2019, patients who underwent complete resection of IMA were extracted from the prospective database. Multivariable Cox-regression analysis and inverse probability of treatment weight (IPTW) - adjusted log-rank test for 5-year recurrence-free survival (RFS) were performed. STAS was observed in 39.1% (53 out of 133). The STAS (+) group shows larger tumor size (2.9 ± 2.4 cm vs 3.8 ± 2.4 cm, p = 0.031) and higher incidence of lympho-vascular invasion (6 [7.5%] vs 18 [34.0%], p < 00.001) compared to the STAS (-) group. The 5-year RFS was 66.1% in the STAS (+) group and 91.8% in the STAS (-) group (p < 00.001), and the incidence of locoregional recurrence was significantly higher in the STAS (+) group than the STAS (-) group (1 [1.2%] vs 12 [22.6%], p < 00.001). Multivariable analysis revealed that STAS was associated with poor prognosis for all-recurrence (hazard ratio 2.81, 95% confidence interval 1.01-7.81, p = 0.048). After IPTW adjustment, 5-year RFS was 66.3% in the STAS (+) group and 92.9% in the STAS (-) group (p = 0.007), and risk for locoregional recurrence was greater in the STAS (+) group than the STAS (-) group (1.1 [0.9%] vs 20.8 [16.6%], p < 00.001). STAS showed negative prognostic impact on all-recurrence, especially due to locoregional recurrence, after curative resection of IMA.
1 October 2023 in Interdisciplinary CardioVascular and Thoracic Surgery
The purpose of this study was to explore the safety and feasibility of video-assisted thoracic surgery (VATS) total thymectomy via the single-port subxiphoid approach compared with the intercostal approach From January 2018 to May 2022, patients who underwent VATS total thymectomy via the subxiphoid or unilateral intercostal approach and diagnosed with Masaoka-Koga stage I-II, non-myasthenic thymoma were included in this study. Perioperative outcomes, immediate and long-term pain evaluations were compared in a propensity score matching analysis. In total, 95 patients were included and underwent the subxiphoid approach (n = 37) and the intercostal approach (n = 58). Propensity score yield two well-matched cohort of 30 patients and there were no significant demographical imbalance between the two groups. Compared with the intercostal approach, the subxiphoid group demonstrated favourable perioperative outcomes including the intraoperative blood loss (P = 0.025) and the median duration of hospital stay (P = 0.083). The immediate and long-term pain evaluations revealed that the subxiphoid group reported lower visual analogue scales at postoperative 24 hours and lower total doses of fentanyl bolus infusions during hospitalization (p = 0.004 and 0.018, respectively), along with lower long-term neuropathic pain scale scores (p = 0.005) than patients in the intercostal group. VATS thymectomy via the single-port subxiphoid approach showed favourable perioperative outcomes compared to the intercostal approach. Moreover, the subxiphoid approach seemed both to cause minimal immediate postoperative pain and to have advantages in reducing long-term neuropathic pain compared with the intercostal approach. B2207-771-101 (Seoul National University Bundang Hospital, July 13th, 2022)
Joon Seok Lee, M.D., Kyung Hwan Kim, M.D., Ph.D., Jae Woong Choi, M.D., Ho Young Hwang, M.D., Ph.D., and Ki-Bong Kim, M.D., Ph.D.. Korean J Thorac Cardiovasc Surg 2018;51:367-75. https://doi.org/10.5090/kjtcs.2018.51.6.367
Background: This study evaluated the prognostic significance of quantitatively assessed interstitial lung abnormalities (ILAs) after lung cancer surgery. Methods: We included patients with pathologic stage I non-small-cell lung cancer (NSCLC) who underwent segmentectomy or lobectomy. ILAs were quantified using deep learning texture analysis software. Five-year overall survival (OS) was compared before and after propensity score matching. Competing risks for lung cancer and non-cancer mortality were also analyzed. Results: Among the 1711 patients, 263 (15.4%) comprised the ILA group. The ILA group was older and had a higher proportion of smokers and pathologic stage IB cases (all p < 0.001). The median follow-up period was 48.0 months. Before matching, 5-year OS was significantly worse in the ILA group than in the non-ILA group (82.5% vs. 93.4%, p < 0.001). After 2:1 matching (N = 697), 5-year OS remained lower in the ILA group (85.8% vs. 91.1%, p = 0.025). Multivariable Cox regression analysis showed that the presence of ILAs was associated with increased risk of all-cause mortality (HR 1.52, 95% CI 1.05–2.18, p = 0.025). Restricted cubic spline analysis revealed a nonlinear increase in mortality risk with greater fibrotic ILA burden. In competing risk analysis, death from lung cancer was similar between groups (2.9% vs. 4.2%, p = 0.3), whereas death from other causes was significantly higher in the ILA group (13.0% vs. 3.7%, p < 0.001). Conclusions: Quantitative assessment of ILAs may provide prognostic value in resected stage I NSCLC, particularly in patients with fibrotic changes.